UBS Global Healthcare Conference
Patagonia Pharmaceuticals is excited to attend the 2015 UBS Global Healthcare Conference in New York, May 18-20. This conference provides a forum to discuss the latest developments across the entire healthcare sector. Please contact info@patagoniarx.com if you would like to connect! #patagonia #ubs #healthcare #conference #global #newyork #orphan #disease #medicine #dermatology
Patagonia engages Torreya Capital
Torreya Capital, a division of the Financial West Investment Group, member FINRA/SIPC, is a leading corporate finance advisory boutique serving companies in the life sciences industry.
Founded by Tim Opler and Mark Simon, Torreya has grown to have 20 professionals and a global presence in life sciences advisory. Torreya has successfully completed more than a 100 assignments since they started in August 2007. Torreya conducts business globally from two offices: New York
Dr. Jonathan K. Wilkin, MD, FAAD, joins Patagonia's Advisory Board
Patagonia Pharmaceuticals is delighted to announce that Dr. Jonathan K. Wilkin, MD, FAAD, has joined Patagonia's growing Advisory Board. Dr. Wilkin is the founding Director (retired) of the Division of Dermatology and Dental Products at the US Food and Drug Administration. Before going to the FDA, he was Director of Dermatology at the Ohio State University and Professor of Pharmacology and Medicine. He has over 130 publications in dermatology and clinical pharmacology.
D
